NLS Pharmaceutics AG
NLSP
$1.47
-$0.053-3.48%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 552.80K | 552.80K | 897.70K | 897.70K | 1.65M |
| Total Receivables | 81.00K | 81.00K | 35.10K | 35.10K | 64.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 297.30K | 297.30K | 69.00K | 69.00K | 491.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 261.40K | 261.40K | 821.30K | 821.30K | 37.80K |
| Total Current Assets | 1.19M | 1.19M | 1.82M | 1.82M | 2.25M |
|
|
|||||
| Total Current Assets | 1.19M | 1.19M | 1.82M | 1.82M | 2.25M |
| Net Property, Plant & Equipment | 1.00K | 1.00K | 6.70K | 6.70K | 12.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 16.90K | 16.90K | 12.60K |
| Total Assets | 1.19M | 1.19M | 1.85M | 1.85M | 2.27M |
|
|
|||||
| Total Accounts Payable | 4.58M | 4.58M | 4.63M | 4.63M | 3.11M |
| Total Accrued Expenses | 1.42M | 1.42M | 1.54M | 1.54M | 779.30K |
| Short-term Debt | 1.71M | 1.71M | 1.63M | 1.63M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 112.60K | 112.60K | -- |
| Total Other Current Liabilities | -- | -- | 112.60K | 112.60K | -- |
| Total Current Liabilities | 7.72M | 7.72M | 7.92M | 7.92M | 3.89M |
|
|
|||||
| Total Current Liabilities | 7.72M | 7.72M | 7.92M | 7.92M | 3.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.71M | 1.71M | 1.63M | 1.63M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.74M | 2.74M | 2.76M | 2.76M | 2.66M |
| Total Liabilities | 10.46M | 10.46M | 10.68M | 10.68M | 6.56M |
|
|
|||||
| Common Stock & APIC | 63.14M | 63.14M | 61.76M | 61.76M | 61.66M |
| Retained Earnings | -72.41M | -72.41M | -70.37M | -70.37M | -65.81M |
| Treasury Stock & Other | 4.20K | 4.20K | -222.90K | -222.90K | -131.10K |
| Total Common Equity | -9.27M | -9.27M | -8.83M | -8.83M | -4.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.27M | -9.27M | -8.83M | -8.83M | -4.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.27M | -9.27M | -8.83M | -8.83M | -4.29M |
|
|
|||||